Showing results (121-130 of 421) with videos related to

Sort By:
Pageof 43
Journal of Clinical Immunology|March 1, 1989
Appearance of neuropeptides in ascitic fluid after peritoneal therapy with interleukin-2 and lymphokine-activated killer cells for intraabdominal malignancyS A Schiogolev, E J Goetzl, W J Urba, et al.
Science (New York, N.Y.)|December 21, 1990
Peripheral clonal elimination of functional T cellsL A Jones, L T Chin, D L Longo, et al.
Therapeutic Immunology|February 1, 1995
Induction of a CD8+ cytotoxic T lymphocyte response to soluble antigen given together with a novel muramyl dipeptide adjuvant, N-acetyl-D-glucosaminyl-(beta 1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine (GMDP)R L Hornung, D L Longo, V L Gowda, et al.
Archives of Pathology & Laboratory Medicine|June 1, 1978
Pathology of the adrenal gland in refractory low-renin hypertensionD L Longo, J A Esterly, C E Grim, et al.
The Journal of Experimental Medicine|September 1, 1984
Self-recognition specificity expressed by T cells from nude mice. Absence of detectable Ia-restricted T cells in nude mice that do exhibit self-K/D-restricted T cell responsesA M Kruisbeek, M L Davis, L A Matis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancerB D Curti, A C Ochoa, G C Powers, et al.
Hybridoma|February 10, 1998
Anti-idiotype monoclonal antibodies specific for the MOPC167 anti-phosphocholine transgene-encoded antibodyD G Sieckmann, E Martin, G Guelde, et al.
The American Journal of Surgical Pathology|August 1, 1990
Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlationsP Lardelli, M A Bookman, J Sundeen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1985
In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the class I, class II, and Mls-reactive proliferating T cell subsetA M Kruisbeek, S Bridges, J Carmen, et al.
Clinical Pharmacology and Therapeutics|November 3, 2016
Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple MyelomaJ P Laubach, C E Paba Prada, P G Richardson, et al.
Pageof 43